Examining how the Inflation Reduction Act affects insulin costs and diabetes care for Medicare patients
Official title: Insulin Affordability: Unpacking the Impact of the Inflation Reduction Act on Diabetes Outcomes and Equity in Medicare
Funded at Yale University · NIH-11023634 · Data updated 2026-11-12
This study looks at how the Inflation Reduction Act helps make insulin more affordable for people on Medicare, focusing on how capping out-of-pocket costs affects their health and access to diabetes care.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project start | January 1, 2025 |
| Project end | November 30, 2028 |
| Funding year | 2025 |
| Award (this year) | $749,566 |
| NIH project number | 1R01DK141666-01 |
| Project ID | NIH-11023634 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are Medicare beneficiaries aged 65 and older who require insulin for managing their diabetes.
✕Less likely to help
Patients who are not enrolled in Medicare or do not require insulin for diabetes management may not benefit from this research.
What this research studies
This research investigates the effects of the Inflation Reduction Act on insulin affordability for Medicare beneficiaries. It aims to understand how capping out-of-pocket payments for insulin impacts health outcomes and equity in diabetes care. By analyzing data from Medicare claims and other sources, the study will evaluate changes in insulin utilization and clinical outcomes before and after the implementation of the Act. The goal is to identify barriers to diabetes care and propose effective solutions for improving access to insulin.
Why it matters
Potential benefit: If successful, this research could lead to improved access to insulin and better health outcomes for Medicare patients with diabetes.
How similar studies have gone: Previous research has shown that policy changes affecting medication costs can significantly improve access and health outcomes for patients, suggesting potential success for this approach.
Where this research is happening
-
Yale University
New Haven, United States Active
Researchers
- Principal investigator: Lipska, Kasia Joanna — Yale University
- Study coordinator: Lipska, Kasia Joanna
Related research
Other NIH-funded projects on the same topics.
-
HEARTS hypertension and diabetes care in Guatemala
This grant tests how well the HEARTS primary care model works in Guatemala to improve blood pressure and blood sugar control for patients.
-
Retinal signals in early diabetes and how they affect vision
This grant looks at how diabetes changes the signals in the retina that control vision, with a focus on inner retinal cells and how these changes may lead to vision problems.
-
Integrated Heart Health: A HEARTS-based approach to hypertension and diabetes in Guatemala
A study tests a team-based, stepwise care model to improve blood pressure and blood sugar control for people with both hypertension and diabetes in Guatemala.
-
Bringing WHO HEARTS-D diabetes care into Bangladesh cities
A program to help urban clinics in Bangladesh adopt WHO HEARTS-D guidelines to improve detection, treatment, and control of type 2 diabetes.
-
AI-powered fundus imaging to screen for type 2 diabetes
A mobile AI tool uses eye images to help screen adults for type 2 diabetes in clinics or communities.
-
AI-powered eye imaging to screen for type 2 diabetes with a mobile phone
A plan to use AI on smartphone retinal images to help spot type 2 diabetes early, especially in people who may not have easy access to care.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.